Michel Vounatsos
2017
In 2017, Michel Vounatsos earned a total compensation of $13.7M as Chief Executive Officer at Biogen, a 136% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $18,881 |
|---|---|
| Non-Equity Incentive Plan | $2,502,500 |
| Salary | $1,087,885 |
| Stock Awards | $9,868,540 |
| Other | $186,567 |
| Total | $13,664,373 |
Vounatsos received $9.9M in stock awards, accounting for 72% of the total pay in 2017.
Vounatsos also received $18.9K of change in pension value and nonqualified deferred compensation earnings, $2.5M in non-equity incentive plan, $1.1M in salary and $186.6K in other compensation.
Rankings
In 2017, Michel Vounatsos' compensation ranked 350th out of 14,666 executives tracked by ExecPay. In other words, Vounatsos earned more than 97.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 350 out of 14,666 | 98th |
Division Manufacturing | 112 out of 5,770 | 98th |
Major group Chemicals And Allied Products | 29 out of 2,074 | 99th |
Industry group Drugs | 20 out of 1,730 | 99th |
Industry Biological Products, Except Diagnostic Substances | 3 out of 316 | 99th |
Source: SEC filing on April 27, 2018.
Vounatsos' colleagues
We found eight more compensation records of executives who worked with Michel Vounatsos at Biogen in 2017.
2017
George Scangos
Biogen
Chief Executive Officer
2017
Kenneth DiPietro
Biogen
Former Executive Vice President, Human Resources
2017
Michael Ehlers
Biogen
Executive Vice President, Research & Development
2017
Susan Alexander
Biogen
Chief Legal Officer
2017
Paul McKenzie
Biogen
Executive Vice President, Pharmaceutical Operations & Technology
2017
Paul Clancy
Biogen
Chief Financial Officer
2017
Gregory Covino
Biogen
Chief Accounting Officer
2017
Jeffrey Capello
Biogen